Song Lin

Song Lin is a seasoned professional in drug metabolism and pharmacokinetics (DMPK) with extensive experience across multiple prestigious organizations. Currently serving as Sr. Director of DMPK at Astex Pharmaceuticals since August 2019, Song Lin previously held roles such as Director of Safety and DMPK at UNITY Biotechnology and Director of DMPK at Alliance Pharma Inc., where responsibilities included managing drug discovery and development projects. Prior experience includes leadership positions at Novartis Vaccine and Diagnostics as Investigator III and at Chiron Corporation as Principal Specialist, focusing on oncology and infectious disease research. Song Lin began the career at Covance Laboratories as Manager of Metabolic Chemistry and has contributed significantly to various drug development initiatives since the mid-1990s. Educational qualifications include a Master's degree from the University of Alberta in Folate and One Carbon Metabolism and a Master's degree in Anatomical Sciences from Zhongshan University.